New injection could halt leading cause of blindness in seniors
Disease control
Ongoing
This late-stage clinical trial is testing whether daily injections of an experimental drug called elamipretide can slow the progression of dry age-related macular degeneration (AMD), a leading cause of vision loss in older adults. The study involves 313 participants who will rece…
Phase: PHASE3 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC